Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on January 4, 2006
Journal of the American Society of Nephrology
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2005080859
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
ASN.2005080859v1
ASN.2005080859v2
17/2/368    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galkina, E.
Right arrow Articles by Ley, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galkina, E.
Right arrow Articles by Ley, K.

FRONTIERS IN NEPHROLOGY

Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy

Elena Galkina and Klaus Ley 1

Department of Biomedical Engineering and Cardiovascular Research Center, University of Virginia, Health Sciences Center, Charlottesville, Virginia


1 To whom correspondence should be addressed. E-mail: klausley{at}virginia.edu.


  Abstract

Different types of activated leukocytes play a crucial role in the pathogenesis of most kidney diseases from acute to chronic stages; however, diabetic nephropathy was not considered an inflammatory disease in the past. This view is changing now because there is a growing body of evidence implicating inflammatory cells at every stage of diabetic nephropathy. Renal tissue macrophages, T cells, and neutrophils produce various reactive oxygen species, proinflammatory cytokines, metalloproteinases, and growth factors, which modulate the local response and increase inflammation within the diabetic kidney. Although the precise mechanisms that direct leukocyte homing into renal tissues are not fully identified, it has been reported that intercellular adhesion molecule-1 and the chemokines CCL2 and CX3CL1 probably are involved in leukocyte migration in diabetic nephropathy. This review focuses on the molecular mechanisms of leukocyte recruitment into the diabetic kidney and the involvement of immigrated immune cells in the damage to renal tissues.


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
S. C.W. Tang, L. Y.Y. Chan, J. C.K. Leung, A. S. Cheng, K. W. Chan, H. Y. Lan, and K. N. Lai
Bradykinin and high glucose promote renal tubular inflammation
Nephrol. Dial. Transplant., November 18, 2009; (2009) gfp599v1.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D. Min, J. G. Lyons, J. Bonner, S. M. Twigg, D. K. Yue, and S. V. McLennan
Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy
Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1229 - F1237.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Scherer, W. Gwinner, M. Mengel, T. Kirsch, F. Raulf, J. D. Szustakowski, N. Hartmann, F. Staedtler, G. Engel, J. Klupp, et al.
Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months
Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2567 - 2575.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. L. Burke, M. G. Frid, C. L. Kunrath, V. Karoor, A. Anwar, B. D. Wagner, D. Strassheim, and K. R. Stenmark
Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment
Am J Physiol Lung Cell Mol Physiol, August 1, 2009; 297(2): L238 - L250.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
T. Kosugi, T. Nakayama, M. Heinig, L. Zhang, Y. Yuzawa, L. G. Sanchez-Lozada, C. Roncal, R. J. Johnson, and T. Nakagawa
Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice
Am J Physiol Renal Physiol, August 1, 2009; 297(2): F481 - F488.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
M. A. Niewczas, L. H. Ficociello, A. C. Johnson, W. Walker, E. T. Rosolowsky, B. Roshan, J. H. Warram, and A. S. Krolewski
Serum Concentrations of Markers of TNF{alpha} and Fas-Mediated Pathways and Renal Function in Nonproteinuric Patients with Type 1 Diabetes
Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 62 - 70.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. F. Navarro-Gonzalez and C. Mora-Fernandez
The Role of Inflammatory Cytokines in Diabetic Nephropathy
J. Am. Soc. Nephrol., March 1, 2008; 19(3): 433 - 442.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
V. Ninichuk, S. Clauss, O. Kulkarni, H. Schmid, S. Segerer, E. Radomska, D. Eulberg, K. Buchner, N. Selve, S. Klussmann, et al.
Late Onset of Ccl2 Blockade with the Spiegelmer mNOX-E36-3'PEG Prevents Glomerulosclerosis and Improves Glomerular Filtration Rate in db/db Mice
Am. J. Pathol., March 1, 2008; 172(3): 628 - 637.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Daniel, K. Schaub, K. Amann, J. Lawler, and C. Hugo
Thrombospondin-1 Is an Endogenous Activator of TGF-{beta} in Experimental Diabetic Nephropathy In Vivo
Diabetes, December 1, 2007; 56(12): 2982 - 2989.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
V. Ninichuk, A. G. Khandoga, S. Segerer, P. Loetscher, A. Schlapbach, L. Revesz, R. Feifel, A. Khandoga, F. Krombach, P. J. Nelson, et al.
The Role of Interstitial Macrophages in Nephropathy of Type 2 Diabetic db/db Mice
Am. J. Pathol., April 1, 2007; 170(4): 1267 - 1276.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. Lee, W. Kim, S.-O. Moon, M. J. Sung, D. H. Kim, K. P. Kang, K. Y. Jang, S. Y. Lee, B. H. Park, G. Y. Koh, et al.
Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes
Nephrol. Dial. Transplant., February 1, 2007; 22(2): 396 - 408.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. M. Sasser, J. C. Sullivan, J. L. Hobbs, T. Yamamoto, D. M. Pollock, P. K. Carmines, and J. S. Pollock
Endothelin A Receptor Blockade Reduces Diabetic Renal Injury via an Anti-Inflammatory Mechanism
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 143 - 154.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Schmid, A. Boucherot, Y. Yasuda, A. Henger, B. Brunner, F. Eichinger, A. Nitsche, E. Kiss, M. Bleich, H.-J. Grone, et al.
Modular Activation of Nuclear Factor-{kappa}B Transcriptional Programs in Human Diabetic Nephropathy
Diabetes, November 1, 2006; 55(11): 2993 - 3003.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673